Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical Chemistry and Laboratory Medicine
|
March 12, 2021
Evaluation of the automated LIAISON<sup>®</sup> SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies
Fabrizio Bonelli, Frank A Blocki, Tina Bunnell, et al.
Respiratory Investigation
|
October 4, 2025
The LIAISON® Legionella Urinary Ag assay: A novel high-throughput, fully automated dual-antigen detection method with improved sensitivity and expanded Legionella species and serogroup coverage
Serena Ferraiuolo, Farah Bou Nasser Eddine, Deborah Ferrante, et al.
American Heart Journal
|
December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale
Claudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Circulation Research
|
November 20, 2014
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial
Robert C Schutt, Barry H Trachtenberg, John P Cooke, et al.
Cell Transplantation
|
November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
Doris A Taylor, Emerson C Perin, James T Willerson, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA
|
November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial
Jay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical Chemistry and Laboratory Medicine
|
March 12, 2021
Evaluation of the automated LIAISON<sup>®</sup> SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies
Fabrizio Bonelli, Frank A Blocki, Tina Bunnell, et al.
Respiratory Investigation
|
October 4, 2025
The LIAISON® Legionella Urinary Ag assay: A novel high-throughput, fully automated dual-antigen detection method with improved sensitivity and expanded Legionella species and serogroup coverage
Serena Ferraiuolo, Farah Bou Nasser Eddine, Deborah Ferrante, et al.
American Heart Journal
|
December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale
Claudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Circulation Research
|
November 20, 2014
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial
Robert C Schutt, Barry H Trachtenberg, John P Cooke, et al.
Cell Transplantation
|
November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial
Doris A Taylor, Emerson C Perin, James T Willerson, et al.
Circulation Research
|
August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
JAMA
|
March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial
Emerson C Perin, James T Willerson, Carl J Pepine, et al.
JAMA
|
November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial
Jay H Traverse, Timothy D Henry, Carl J Pepine, et al.
JAMA
|
November 16, 2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial
Jay H Traverse, Timothy D Henry, Stephen G Ellis, et al.
Page
of 3